Rachel Trent, PA
Medical · San Diego, CANPI 1306470372
Payments from drug & device makers
Across 103 payments — averaging $36.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$517
- Amgen$309
- Edwards Lifesciences$239
- Lilly USA, LLC$234
- Phadia US Inc.$211
- Bioventus LLC$194
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,69798%
- Education$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $517 |
| Amgen | 7 | $309 |
| Edwards Lifesciences | 2 | $239 |
| Lilly USA, LLC | 6 | $234 |
| Phadia US Inc. | 7 | $211 |
| Bioventus LLC | 9 | $194 |
| Astellas Pharma US Inc | 2 | $188 |
| Stryker | 1 | $165 |
| Exact Sciences | 7 | $148 |
| Pacira Therapeutics, Inc. | 4 | $145 |
| Organon | 2 | $142 |
| Boston Scientific | 1 | $131 |
| Pfizer | 5 | $129 |
| Hologic Sales And Service, LLC | 5 | $120 |
| Amarin Pharma, Inc. | 1 | $112 |
| Johnson & Johnson | 4 | $101 |
| Dexcom, Inc. | 1 | $100 |
| Viiv Healthcare Company | 3 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $76 |
| Novo Nordisk | 3 | $58 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| AbbVie | 2 | $49 |
| Coopersurgical, Inc. | 1 | $42 |
| Bayer | 2 | $42 |
| Philips North America LLC | 2 | $40 |
| Novartis | 2 | $36 |
| Boehringer Ingelheim | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Nevro Corp. | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Si-bone, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$195
- CLARIFIX CRYOTHERAPY DEVICE$165
- BREZTRI$125
- FARXIGA$125
- Veozah$122
- Repatha$122
- EVENITY$122
- MOUNJARO$116
- Vascepa$112
- NEXPLANON$104
How this compares
$3,763 in reported general payments places this provider in the 80th percentile of 2,087 medical providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $1,428 |
| Celecoxib | 15 | $602 |
| Atorvastatin Calcium | 64 | $594 |
| Gabapentin | 50 | $592 |
| Diclofenac Sodium | 20 | $562 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $544 |
| Omeprazole | 29 | $345 |
| Fluticasone Propionate | 28 | $272 |
| Chlorthalidone | 14 | $253 |
| Metformin Hcl | 41 | $239 |
| Trazodone Hcl | 26 | $216 |
| Lovastatin | 12 | $185 |
| Amlodipine Besylate | 37 | $183 |
| Hydroxyzine Hcl | 30 | $173 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 11 | $165 |
Paid to pharmacies, not to this prescriber.
Other medical in San Diego
- Cheryl KyinnSan Diego$103K
- Touraj YariSan Diego$27K
- Aaron WillcottSan Diego$23K
- Yuchao JinSan Diego$22K
- Carter CopelandSan Diego$17K
- Cameron ChanSan Diego$16K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.